Skip to Content
Merck
CN
  • Moderate exercise training provides left ventricular tolerance to acute pressure overload.

Moderate exercise training provides left ventricular tolerance to acute pressure overload.

American journal of physiology. Heart and circulatory physiology (2010-12-28)
Daniel Moreira-Gonçalves, Tiago Henriques-Coelho, Hélder Fonseca, Rita Maria Ferreira, Francisco Amado, Adelino Leite-Moreira, José Alberto Duarte
ABSTRACT

The present study evaluated the impact of moderate exercise training on the cardiac tolerance to acute pressure overload. Male Wistar rats were randomly submitted to exercise training or sedentary lifestyle for 14 wk. At the end of this period, the animals were anaesthetized, mechanically ventilated, and submitted to hemodynamic evaluation with biventricular tip pressure manometers. Acute pressure overload was induced by banding the descending aorta to induce a 60% increase of peak systolic left ventricular pressure during 120 min. This resulted in the following experimental groups: 1) sedentary without banding (SED + Sham), 2) sedentary with banding (SED + Band), and 3) exercise trained with banding (EX + Band). In response to aortic banding, SED + Band animals could not sustain the 60% increase of peak systolic pressure for 120 min, even with additional narrowing of the banding. This was accompanied by a reduction of dP/dt(max) and dP/dt(min) and a prolongation of the time constant tau, indicating impaired systolic and diastolic function. This impairment was not observed in EX + Band (P < 0.05 vs. SED + Band). Additionally, compared with SED + Band, EX + Band presented less myocardial damage, exhibited attenuated protein expression of active caspase-3 and NF-κB (P < 0.016), and showed less protein carbonylation and nitration (P < 0.05). These findings support our hypothesis that exercise training has a protective role in the modulation of the early cardiac response to pressure overload.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Nitrotyrosine Antibody, clone 2A8.2, clone 2A8.2, Chemicon®, from mouse